Literature DB >> 30209362

OCT4B mediates hypoxia-induced cancer dissemination.

Sheng-Chieh Lin1,2, Chi-Hsiu Chung3, Chih-Hung Chung3, Ming-Han Kuo1, Cheng-Han Hsieh4,5, Yu-Fan Chiu1, Yi-Shing Shieh6, Yu-Ting Chou7, Cheng-Wen Wu8,9,10,11.   

Abstract

Hypoxia, the reduction of oxygen levels in cells or tissues, elicits a set of genes to adjust physiological and pathological demands during normal development and cancer progression. OCT4, a homeobox transcription factor, is essential for self-renewal of embryonic stem cells, but little is known about the role of OCT4 in non-germ-cell tumorigenesis. Here, we report that hypoxia stimulates a short isoform of OCT4, called OCT4B, via a HIF2α-dependent pathway to induce the epithelial-mesenchymal transition (EMT) and facilitate cancer dissemination. OCT4B overexpression decreased epithelial barrier properties, which led to an increase in cell migration and invasion in lung cancer cells. OCT4B knockdown attenuated HIF2α-induced EMT and inhibited cancer dissemination in cell-line and animal models. We observed that OCT4B bound the SLUG promoter and enhanced its expression, and SLUG silencing inhibited OCT4B-mediated EMT, accompanied with decreased cell migration and invasion. Correlation analysis revealed that OCT4B expression was significantly associated with the SLUG level in lung tumors. These results provide novel insights into OCT4B-mediated oncogenesis in cancer dissemination.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30209362     DOI: 10.1038/s41388-018-0487-6

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  39 in total

1.  The hypoxia-associated factor switches cells from HIF-1α- to HIF-2α-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion.

Authors:  Mei Yee Koh; Robert Lemos; Xiuping Liu; Garth Powis
Journal:  Cancer Res       Date:  2011-04-21       Impact factor: 12.701

2.  Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  L Crinò; W Weder; J van Meerbeeck; E Felip
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

3.  A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts.

Authors:  Ronghui Li; Jialiang Liang; Su Ni; Ting Zhou; Xiaobing Qing; Huapeng Li; Wenzhi He; Jiekai Chen; Feng Li; Qiang Zhuang; Baoming Qin; Jianyong Xu; Wen Li; Jiayin Yang; Yi Gan; Dajiang Qin; Shipeng Feng; Hong Song; Dongshan Yang; Biliang Zhang; Lingwen Zeng; Liangxue Lai; Miguel Angel Esteban; Duanqing Pei
Journal:  Cell Stem Cell       Date:  2010-06-17       Impact factor: 24.633

4.  Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma.

Authors:  Jin-Yuan Shih; Meng-Feng Tsai; Tzu-Hua Chang; Yih-Leong Chang; Ang Yuan; Chong-Jen Yu; Shin-Bey Lin; Geou-Yarh Liou; Meng-Larn Lee; Jeremy J W Chen; Tse-Ming Hong; Shuenn-Chen Yang; Jen-Liang Su; Yung-Chie Lee; Pan-Chyr Yang
Journal:  Clin Cancer Res       Date:  2005-11-15       Impact factor: 12.531

5.  The carboxy-terminal transactivation domain of Oct-4 acquires cell specificity through the POU domain.

Authors:  A Brehm; K Ohbo; H Schöler
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

6.  Oct4 distribution and level in mouse clones: consequences for pluripotency.

Authors:  Michele Boiani; Sigrid Eckardt; Hans R Schöler; K John McLaughlin
Journal:  Genes Dev       Date:  2002-05-15       Impact factor: 11.361

7.  Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1.

Authors:  S Bhattacharya; C L Michels; M K Leung; Z P Arany; A L Kung; D M Livingston
Journal:  Genes Dev       Date:  1999-01-01       Impact factor: 11.361

8.  Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs.

Authors:  Michael S Wiesener; Jan Steffen Jürgensen; Christian Rosenberger; Charlotte K Scholze; Jan H Hörstrup; Christina Warnecke; Stefano Mandriota; Ingo Bechmann; Ulrich A Frei; Christopher W Pugh; Peter J Ratcliffe; Sebastian Bachmann; Patrick H Maxwell; Kai-Uwe Eckardt
Journal:  FASEB J       Date:  2002-12-17       Impact factor: 5.191

9.  Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation.

Authors:  Cheng-Jun Hu; Li-Yi Wang; Lewis A Chodosh; Brian Keith; M Celeste Simon
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

10.  SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.

Authors:  Poornima Bhat-Nakshatri; Hitesh Appaiah; Christopher Ballas; Patricia Pick-Franke; Robert Goulet; Sunil Badve; Edward F Srour; Harikrishna Nakshatri
Journal:  BMC Cancer       Date:  2010-08-06       Impact factor: 4.430

View more
  3 in total

1.  Deregulation of Stemness-Related Genes in Endometriotic Mesenchymal Stem Cells: Further Evidence for Self-Renewal/Differentiation Imbalance.

Authors:  Parisa Mashayekhi; Mehrdad Noruzinia; Sepideh Khodaverdi
Journal:  Iran Biomed J       Date:  2020-04-18

2.  Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.

Authors:  Hao-Fan Wang; Sha-Sha Wang; Min Zheng; Lu-Ling Dai; Ke Wang; Xiao-Lei Gao; Ming-Xin Cao; Xiang-Hua Yu; Xin Pang; Mei Zhang; Jing-Biao Wu; Jia-Shun Wu; Xiao Yang; Ya-Jie Tang; Yu Chen; Ya-Ling Tang; Xin-Hua Liang
Journal:  Cell Prolif       Date:  2019-04-03       Impact factor: 6.831

Review 3.  Cancer Plasticity: The Role of mRNA Translation.

Authors:  Laura J Lee; David Papadopoli; Michael Jewer; Sonia Del Rincon; Ivan Topisirovic; Mitchell G Lawrence; Lynne-Marie Postovit
Journal:  Trends Cancer       Date:  2020-10-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.